Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity

• Timothy M. Coskran,

  Affiliation Drug Safety Research & Development, Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Zhijie Jiang,

  Affiliation Department of Computer Science, University of Miami, Miami, Florida, United States of America

  ⨯
• James E. Klaunig,

  Affiliation Environmental Health, Indiana University, Bloomington, Indiana, United States of America

  ⨯
• Dixie L. Mager,

  Affiliation Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Leslie Obert,

  Affiliation GlaxoSmithKline plc, King of Prussia, Pennsylvania, United States of America

  ⨯
• Andrew Robertson,

  Affiliation Drug Safety Research & Development, Pfizer Inc., Groton, Connecticut, United States of America

  ⨯
• Nicholas Tsinoremas,

  Affiliation Department of Computer Science, University of Miami, Miami, Florida, United States of America

  ⨯
• Zemin Wang,

  Affiliation Environmental Health, Indiana University, Bloomington, Indiana, United States of America

  ⨯
• Mark Gosink

  * E-mail: Mark.M.Gosink@Pfizer.com

  Affiliation Drug Safety Research & Development, Pfizer Inc., Groton, Connecticut, United States of America

  http://orcid.org/0000-0003-3009-3941

  ⨯